What is the equivalent dosage of Morphine Sulfate Extended Release (MSER) to OxyContin (oxycodone) 20mg twice daily (bid)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 5, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

OxyContin 20mg BID to MSER Conversion

OxyContin 20mg twice daily (40mg total daily) converts to approximately 60mg of Morphine Sulfate Extended Release (MSER) per day, typically administered as 30mg twice daily.

Calculation Method

The conversion is based on the established opioid equivalency ratio between oxycodone and morphine:

  • Total daily oxycodone dose: 20mg × 2 = 40mg/day 1
  • Conversion factor: Oxycodone has a conversion factor of 1.5 to morphine milligram equivalents (MME) 1, 2
  • Calculation: 40mg oxycodone × 1.5 = 60 MME (morphine equivalents) per day 1, 2

Recommended MSER Dosing

  • Total daily MSER dose: 60mg/day 1, 2
  • Typical administration: 30mg MSER twice daily (BID) to match the extended-release profile 1
  • Alternative: Some clinicians may use 20mg three times daily, though BID dosing better matches the original OxyContin schedule 1

Critical Safety Considerations

Dose reduction is strongly recommended when converting between opioids to account for incomplete cross-tolerance and individual pharmacokinetic variability 1, 3:

  • Reduce the calculated equianalgesic dose by 25-50% when switching opioids 1, 3
  • This would suggest starting with 30-45mg MSER daily (15-22.5mg BID) rather than the full 60mg 1
  • Titrate upward based on pain control and tolerability 1, 3

Important Caveats

The 1.5 conversion factor is widely accepted but shows some variation in clinical practice 1:

  • Some sources cite oxycodone potency as 1.5-2 times that of morphine 1, 4
  • The CDC guideline uses 1.5 as the standard conversion factor 1
  • NCCN cancer pain guidelines also support the 1.5-2 range 1

Equianalgesic conversions are estimates only and cannot account for individual differences in genetics, metabolism, and prior opioid exposure 1, 3, 5:

  • Significant variability exists between clinicians in opioid conversion practices 5
  • Monitor closely for signs of inadequate pain control or opioid toxicity after conversion 3
  • Provide immediate-release morphine for breakthrough pain during the transition period 1

Practical Implementation

For a conservative approach in clinical practice:

  • Start with 45mg MSER daily (22.5mg BID, rounded to available tablet strengths) 1
  • Provide immediate-release morphine 10-15mg every 4 hours as needed for breakthrough pain 1
  • Reassess within 24-48 hours and adjust based on breakthrough medication requirements 1
  • If patient required minimal breakthrough doses and pain was well-controlled on OxyContin, the full 60mg MSER daily may be appropriate 1, 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Equivalencia de Dosis entre Oxicodona y Morfina

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Opioid Conversion Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Oxycodone: a pharmacological and clinical review.

Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico, 2007

Research

Variability in Opioid Equivalence Calculations.

Pain medicine (Malden, Mass.), 2016

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.